KC Safi (@safi_kc) 's Twitter Profile
KC Safi

@safi_kc

Consultant urological & laparoscopic surgeon. FRCS(Urol), FEBU. Endourology/ MIS urologic oncology. Jordan Hospital & Medical center, Amman -Jordan

ID: 709366352830717952

linkhttp://drkhalidsafi.com calendar_today14-03-2016 13:11:32

1,1K Tweet

817 Followers

1,1K Following

Ron Barbosa MD FACS (@rbarbosa91) 's Twitter Profile Photo

🧵for the new residents and students on the meaning of 'French' and 'Gauge'. We've covered this on here in the past, but a lot of new people are starting on surgical rotations, so let's look at them again. As usual, we'll cover their history and what they mean. (1/ )

🧵for the new residents and students on the meaning of 'French' and 'Gauge'.

We've covered this on here in the past, but a lot of new people are starting on surgical rotations, so let's look at them again.

As usual, we'll cover their history and what they mean.
(1/ )
Omer Raheem (@omerraheemmd) 's Twitter Profile Photo

Comprehensive surgical illustrative review of the treatment of ischemic priapism #PenoscrotalDecompress published nature.com/articles/s4144… .⁦IJIR: Your Sexual Medicine Journal⁩ 🙏.⁦Ege Can Serefoglu⁩ #AlanMorey

Comprehensive surgical illustrative review of the treatment of ischemic priapism #PenoscrotalDecompress published nature.com/articles/s4144… .⁦<a href="/yoursexmedjour/">IJIR: Your Sexual Medicine Journal</a>⁩ 🙏.⁦<a href="/drserefoglu/">Ege Can Serefoglu</a>⁩ #AlanMorey
Marc-Olivier Timsit, MD, PhD 🎗️ (@urologieparis) 's Twitter Profile Photo

La supériorité du sasanlimab + BCG vs BCG seul dans les TVNIM représente un tournant pour les urologues dans la prise en charge du cancer de vessie: il s’agit d’une immunothérapie à domicile par voie sous cutanée. En espérant rapidement AMM et remboursement . Association Française d'Urologie - AFU

Juan Gómez Rivas (@jgomezrivas) 's Twitter Profile Photo

Can we do more before surgery in high-risk localized prostate cancer? Neoadjuvant treatment administered before radical prostatectomy is gaining atention as a strategy to improve outcomes in patients with aggressive prostate cancer. This article on UroToday dives into the

Can we do more before surgery in high-risk localized prostate cancer?

Neoadjuvant treatment administered before radical prostatectomy is gaining atention as a strategy to improve outcomes in patients with aggressive prostate cancer. This article on UroToday dives into the
Mohamed_omar (@mohamedendourol) 's Twitter Profile Photo

Mega prostate “300-gram”+ High risk pt+ on Apixapan = Choose 👇 Bipolar Enucleation ✅Hemostasis ✅affordable technology ✅ Easy learning curve ✅OR = 60 min Enucleation Bipolar Enucleation Academy “BEA” New online platform Coming 🔜….. Full video on YouTube platform soon

SIU-Urology (@siu_urology) 's Twitter Profile Photo

Didn’t have an opportunity to connect to the LIVE #eGrandRounds session on #BPH Management? You can now watch it on-demand! Access the webcast for free here:🔗bit.ly/4j9z9yf #SIUAcademy Thomas RW Herrmann StavrosGravas Karin Lehrich Cecilia Cracco

Didn’t have an opportunity to connect to the LIVE #eGrandRounds session on #BPH Management? You can now watch it on-demand! Access the webcast for free here:🔗bit.ly/4j9z9yf

#SIUAcademy
<a href="/trwherrmann/">Thomas RW Herrmann</a> <a href="/StavrosGravas/">StavrosGravas</a> <a href="/KarinLehrich/">Karin Lehrich</a> <a href="/CraccoCecilia/">Cecilia Cracco</a>
UroToday.com (@urotoday) 's Twitter Profile Photo

Managing BCG-unresponsive #BladderCancer: Balancing bladder preservation and cystectomy. Paolo Gontero & Maria Carmen Mir, MD, PhD join Ashish M. Kamat, MD, MBBS in a discussion addressing management approaches for BCG-unresponsive bladder cancer. #WatchNow on UroToday >

Lee Zhao (@lee_c_zhao) 's Twitter Profile Photo

Great video on performing pyeloplasty without transection via Y to V advancement flap. Congrats to Marc-Olivier Timsit, MD, PhD 🎗️ Looking forward to seeing the SP retro version next!

Alfredo Sanchez Urólogo (@lfredosanchez) 's Twitter Profile Photo

•REDO HoLEP POST REZUM• Video where we can compare the results 2 years after REZUM and the final results after HoLEP!!! The question is: Do we make a mistake when choosing the technique? Or is the technique insufficient? I would like to read those who do MIST or REZUM

UroToday.com (@urotoday) 's Twitter Profile Photo

Treatment decision regret after precision prostatectomy: an analysis of patient-reported outcomes predicting decision regret. #AuthorCommentary ✅ Only 3% of patients report significant regret vs. 25–30% after radical prostatectomy. ✅ 83% experience no regret, thanks to better

Treatment decision regret after precision prostatectomy: an analysis of patient-reported outcomes predicting decision regret. #AuthorCommentary 
✅ Only 3% of patients report significant regret vs. 25–30% after radical prostatectomy.
✅ 83% experience no regret, thanks to better
KC Safi (@safi_kc) 's Twitter Profile Photo

The Virtuoso Robotic En Bloc Resection of Bladder Tumour Case 1 youtu.be/gTUv-cq-ICI?si… via YouTube Dr Jeremy Teoh performing the first in human enbloc TURBT Also it would be very useful in harvesting bladder flaps for substitution uretero/ urethroplasties.

Juan Gómez Rivas (@jgomezrivas) 's Twitter Profile Photo

A new systematic review & meta-analysis explores the role of androgen receptor pathway inhibitor (ARPI) monotherapy across prostate cancer stages. •⚖️ Similar overall safety to ADT or ARPI+ADT combo •❤️‍🔥 Fewer hot flushes •⚠️ More breast-related side effects (pain &

A new systematic review &amp; meta-analysis explores the role of androgen receptor pathway inhibitor (ARPI) monotherapy across prostate cancer stages.

•⚖️ Similar overall safety to ADT or ARPI+ADT combo
•❤️‍🔥 Fewer hot flushes
•⚠️ More breast-related side effects (pain &amp;
KC Safi (@safi_kc) 's Twitter Profile Photo

(68) AI Review - Academia.edu AI review of one of my publication that published in J Urol , Interesting to see how AI can be useful to our tool at time writing this manuscript more than 20 yrs ago academia.edu/ai_review/8217…

Medics (@medics3d) 's Twitter Profile Photo

HA3D color coding bed resection planning at work during Challenges in Laparoscopy & Robotics ( CILR ) live surgery session today. Clinical case: Left Kidney, 42*38*42mm tumor, posterior face, upper pole. Surgeon: Prof. Francesco Porpiglia Surgery:Single Port Robot-Assisted Partial Nephrectomy RAPN Porpiglia Francesco

EAU Edu Platform UROONCO (@eau_uroonco) 's Twitter Profile Photo

📹 Tune in to this video discussion between UROONCO RCC associate editor Dr. 𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD and Dr. Pieter De Backer , talking about auxiliary technologies in robotic surgery and the use of AI for intra-operative visual guidance. Learn more here kidney.uroonco.uroweb.org/video/auxiliar…👇 #kidneycancer

European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

NEW: The EAU Guidelines Bot The right answers, seconds away Ask personalised treatment questions and receive instant answers based on the EAU Guidelines. Available in each topic section of the EAU Guidelines. Try it today via the Guidelines page: uroweb.org/guidelines

UroToday.com (@urotoday) 's Twitter Profile Photo

The evolving treatment landscape for #NMIBC beyond BCG. Bogdana Schmidt MD, MPH Huntsman Cancer Institute joins Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center in discussing new frontiers in NMIBC: intravesical combos, FGFR3-targeted agents & patient-centered alternatives to radical cystectomy. #WatchNow >

Steffi Yuen (@steffiyuen) 's Twitter Profile Photo

🎉Our work was published at European Urology today! 🪭Randomized noninferiority trial: Flexible and Navigable Suction Ureteral Access Sheath flexible ureteroscopy #FANS #fURS vs #miniPCNL in 2-3cm renal stone 🔗 doi.org/10.1016/j.euru… #GuohuaZeng #WeiZhu #fansofFANS #UroSoMe

🎉Our work was published at European Urology today! 
🪭Randomized noninferiority trial: Flexible and Navigable Suction Ureteral Access Sheath flexible ureteroscopy #FANS #fURS vs #miniPCNL in 2-3cm renal stone 
🔗 doi.org/10.1016/j.euru…
#GuohuaZeng #WeiZhu #fansofFANS #UroSoMe
UroToday.com (@urotoday) 's Twitter Profile Photo

Landscape of approved and upcoming PSMA imaging agents. Amir Iravani Fred Hutch Cancer Center presents at the 2025 UCSF-UCLA #PSMAConference comparing FDA-approved PSMA PET agents (gallium-68 PSMA-11, DCFPyL, rhPSMA-7.3) for prostate cancer imaging. #WatchNow > bit.ly/4jIwWJM

Landscape of approved and upcoming PSMA imaging agents. <a href="/DrAIravani/">Amir Iravani</a> <a href="/fredhutch/">Fred Hutch Cancer Center</a> presents at the 2025 UCSF-UCLA #PSMAConference comparing FDA-approved PSMA PET agents (gallium-68 PSMA-11, DCFPyL, rhPSMA-7.3) for prostate cancer imaging. #WatchNow &gt; bit.ly/4jIwWJM